1984
DOI: 10.1111/j.1365-2885.1984.tb00873.x
|View full text |Cite
|
Sign up to set email alerts
|

Preparation and properties of monoclonal antibodies to the anabolic agent zeranol

Abstract: Monoclonal antibodies have been produced using two haptens, zeranol-7-hemisuccinate coupled to bovine serum albumin and zeranol-16-carboxypropyl ether coupled to human serum albumin. An assessment of cross-reactivity demonstrated that the monoclonal antibody raised against the 7-hemisuccinate derivative reacted with zeranol (100%), talernol (12%), zearalenone (17%), zearalanone (100%) and alpha- and beta-zearalenol (17% and less than 0.01%, respectively). In contrast the antibodies to the 16-carboxypropyl ethe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

1985
1985
2013
2013

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 8 publications
0
6
0
Order By: Relevance
“…MAbs against ZAL was prepared first by Carter et al . . In the current study, the myeloma/splenocyte fusion yielded two stable hybridomas producing MAbs against ZAL.…”
Section: Resultsmentioning
confidence: 69%
See 1 more Smart Citation
“…MAbs against ZAL was prepared first by Carter et al . . In the current study, the myeloma/splenocyte fusion yielded two stable hybridomas producing MAbs against ZAL.…”
Section: Resultsmentioning
confidence: 69%
“…This fully exposes the difference between analogues. The raised antibodies toward 16‐position hapten are less cross‐reactive with analogues than that of 7‐position hapten .…”
Section: Resultsmentioning
confidence: 99%
“…It has previously been mentioned that anabolic drugs may be employed as growth promoters in animals, and animal feed may be supplemented with antibiotics for prophylactic control of infectious disease. Carter et al (1984) prepared MAbs against the anabolic agent zeranol, and suggested appHcations of this antibody in immunoassays for monitoring residues of zeranol in animal products. Several authors have developed MAbs against antibiotics and suggested their use in immunoassays for detecting the presence of residual antibiotic in animal products, including Van de Water et al (1987), who used a MAb against chloramphenicol for development of a competitive ELISA for determination of chloramphenicol residues in swine muscle tissue.…”
Section: Toxins and Drug Residuesmentioning
confidence: 99%
“…3 A number of immunochemical methods have been developed for the screening of zeranol. [4][5][6][7] However, all the current immunochemical tests exhibit cross-reactivity to a greater or lesser extent with zearalenone, a-zearalenol and b-zearalenol, the three principal toxins produced by Fusarium spp. fungi.…”
Section: Introductionmentioning
confidence: 99%